Tristel PLC TSNLF

Morningstar Rating
$5.74 −0.26 (4.33%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TSNLF is trading within a range we consider fairly valued.
Price
$5.74
Fair Value
LOCK|W&%w^H
Uncertainty
LOCK|<rG^$
1-Star Price
LOCK|mwb%>n
5-Star Price
LOCK|vG>s@<$
Economic Moat
LOCK|!P!?
Capital Allocation

Trading Information

Previous Close Price
$6.00
Day Range
$5.745.74
52-Week Range
$5.006.00
Bid/Ask
$5.01 / $6.01
Shares Outstanding
48.00M
Market Cap
$275.24M
Volume/Avg
200 / 1,135

Key Statistics

Price/Earnings (Normalized)
24.34
Price/Sales
4.26
Dividend Yield (Trailing)
3.31%
Dividend Yield (Forward)
3.31%
Total Yield
3.31%

Company Profile

Tristel PLC’s business is the sale to hospitals of its proprietary chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand and for the sporicidal disinfection of environmental surfaces under the Cache brand. Its operating segments include hospital medical device decontamination products used predominantly for infection control in hospitals; the manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from hospital medical device decontamination and operates geographically in the UK and overseas markets.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
270

Valuation

Metric
TSNLF
Price/Earnings (Normalized)
24.34
Price/Book Value
6.07
Price/Sales
4.26
Price/Cash Flow
19.45
Price/Earnings
TSNLF

Financial Strength

Metric
TSNLF
Quick Ratio
3.45
Current Ratio
4.13
Interest Coverage
41.92
Quick Ratio
TSNLF

Profitability

Metric
TSNLF
Return on Assets (Normalized)
19.65%
Return on Equity (Normalized)
26.79%
Return on Invested Capital (Normalized)
22.55%
Return on Assets
TSNLF

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|Kq?M&Xl>LOCK|>G$134B
Becton Dickinson & Co
BDX
LOCK|b&LOCK|>!F$?$48B
Alcon Inc
ALC
LOCK|D&#fyFGLOCK|?&qk$34B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|?c%P><<LOCK|&Ll>%$31B
ResMed Inc
RMD
LOCK|#kp<J<DmLOCK|cM?jY$31B
West Pharmaceutical Services Inc
WST
LOCK|!y@@Z?FzLOCK|!n$25B
The Cooper Companies Inc
COO
LOCK|^VGZz^RLOCK|wtP&$14B
Baxter International Inc
BAX
LOCK|H@LOCK|>^^n$14B
Solventum Corp
SOLV
LOCK|hGk%!wLOCK|SN@$14B
Align Technology Inc
ALGN
LOCK|%?fKGJxLOCK|FM#K$12B

Sponsor Center